Biology:Dystroglycan

From HandWiki
Short description: Protein


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Dystroglycan is a protein that in humans is encoded by the DAG1 gene.[1][2][3]

Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in Homo sapiens on chromosome 3.[4] There are two exons that are separated by a large intron. The spliced exons code for a protein product that is finally cleaved into two non-covalently associated subunits, [alpha] (N-terminal) and [beta] (C-terminal).

Function

In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton. [alpha]-dystroglycan is extracellular and binds to merosin [alpha]-2 laminin in the basement membrane, while [beta]-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rod-like cytoskeletal protein, absent in Duchenne muscular dystrophy patients. Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan.

Expression

Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues. During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane. Dystroglycan expression in Mus musculus brain and neural retina has also been reported. However, the physiological role of dystroglycan in non-muscle tissues remains unclear.

In December 2022, the implications of abnormal dystroglycan expression and/or O-mannosylation on the pathogenesis of cancer have been reviewed.[5]

Interactions

Dystroglycan has been shown to interact with FYN,[6] C-src tyrosine kinase,[6] Src,[6] NCK1,[6] Grb2,[7] Caveolin 3[8] and SHC1.[6]

See also

References

  1. "Genetic mapping of the mouse neuromuscular mutation kyphoscoliosis". Genomics 25 (1): 207–213. January 1995. doi:10.1016/0888-7543(95)80127-8. PMID 7774920. 
  2. "Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix". Nature 355 (6362): 696–702. February 1992. doi:10.1038/355696a0. PMID 1741056. Bibcode1992Natur.355..696I. 
  3. "Entrez Gene: DAG1 dystroglycan 1 (dystrophin-associated glycoprotein 1)". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1605. 
  4. "Dystroglycan, a scaffold for the ERK-MAP kinase cascade". EMBO Reports 5 (5): 484–489. May 2004. doi:10.1038/sj.embor.7400140. PMID 15071496. 
  5. "Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis". Cancer Cell International 22 (1): 395. December 2022. doi:10.1186/s12935-022-02812-7. PMID 36494657. 
  6. 6.0 6.1 6.2 6.3 6.4 "Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins". Biochemistry 40 (48): 14585–14592. December 2001. doi:10.1021/bi011247r. PMID 11724572. 
  7. "SH3 domain-mediated interaction of dystroglycan and Grb2". The Journal of Biological Chemistry 270 (20): 11711–11714. May 1995. doi:10.1074/jbc.270.20.11711. PMID 7744812. 
  8. "Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members". The Journal of Biological Chemistry 275 (48): 38048–38058. December 2000. doi:10.1074/jbc.M005321200. PMID 10988290. 

Further reading

External links